Newsroom

Newsroom

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

Press Release
Read More

Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project

Literature
Read More

NeoGenomics Reports 11% Revenue Growth to $106 Million in the First Quarter

Press Release
Read More

Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy

Literature
Read More

A comprehensive genomic profiling approach to interrogate hematologic malignancies

Literature
Read More

Analytical development of the RaDaRTM assay, a highly sensitive and specific assay for the monitoring of minimal residual disease

Literature
Read More

Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM

Literature
Read More

Exploitation of Treatment Induced Tumor Lysis to Enhance Sensitivity of ctDNA Analysis: A First-In-Human Pilot Study

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients